Solution conformations of some acyclo nucleoside and nucleotide analogues of antiviral acyclonucleosides, and their substrate/inhibitor properties in several enzyme systems

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 43, Issue 3-4, 1988, Pages 231-242

  Stolarski, Ryszard ^a   Kazimierczuk, Zygmunt ^a   Lassota, Piotr ^a   Shugar, David ^a  

^a UNIVERSITY OF WARSAW   (Poland)

Author keywords

Acyclonucleosides; Cyclic Phosphates; Phosphates; Solution Conformations; Substrate Inhibitor Properties

Indexed keywords

ANTIVIRUS AGENT; ENZYME INHIBITOR; NUCLEOSIDE; NUCLEOTIDE;

ARTICLE; CONFORMATION; ENZYME SPECIFICITY; HYDROLYSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SOLUTION AND SOLUBILITY;

ANTIVIRAL AGENTS; ENZYME INHIBITORS; HYDROLYSIS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR CONFORMATION; NUCLEOSIDES; NUCLEOTIDES; SOLUTIONS; SUBSTRATE SPECIFICITY; SUPPORT, NON-U.S. GOV'T;

EID: 0023972266     PISSN: 09395075     EISSN: 18657125     Source Type: Journal    
DOI: 10.1515/znc-1988-3-414     Document Type: Article

References (43)

1. G. B. Elion, P. A. Furman, J. A. Fyfe, P. De Miranda, L. Beauchamp, and H. J. Schaeffer, Proc. Natl. Acad. Sci. USA 74, 5716-5720 (1977).
2. P. M. Keller, J. A. Fyfe, L. Beauchamp, C. M. Lubbers, P. A. Furman, M. J. Schaeffer, and G. B. Elion, Biochem. Pharmacol. 30, 3071-3077 (1981).
3. E. De Clercq, Antiviral Res., Suppl. 1, 1985, 11-19.
4. P. A. Furman, M. H. St. Clair, and T. Spector, J. Biol. Chem. 259, 9575-9579 (1984).
5. A. Larsson, A. Sundavist, and A.-M. Parnerud, Molec. Pharmacol. 29, 614-621 (1986).
6. D. Shugar, Pure Appl. Chem. 57, 423-440 (1985).
7. J. V. Tuttle and T. A. Krenitsky, J. Biol. Chem. 259, 4065-4069 (1984).
8. A. K. Drabikowska, L. Lissowska, M. Dramiski, A. Zgit-Wróblewska, and D. Shugar, Z. Naturforsch. 42c, 288-296 (1987).
9. R. Stolarski, Z. Kazimierczuk, P. Lassota, and D. Shugar, Z. Naturforsch. 41c, 758-770 (1986).
10. P. Lassota, Z. Kazimierczuk, M. Zan-Kowalczewska, and D. Shugar, Biochem. Biophys. Res. Commun.137, 453-460 (1986).
11. J. Giziewicz and D. Shugar, Acta Biochim. Polon. 22, 87-98 (1975).
12. K. K. Ogilvie, N. Nguyen-Ba, M. F. Gillen, B. K. Radatus, V. O. Cheriyan, H. R. Hanna, K. O. Smith, and K. S. Galloway, Can. J. Chem. 62, 241-252 (1983).
13. A. G. Beaman and R. K. Robins, J. Appl. Chem. 12, 432-437 (1962).
14. J. C. Martin, G. A. Jeffrey, D. P. C. McGee, M. A. Tippic, D. F. Smee, T. R. Matthews, and J. P. Verheyden, J. Med. Chem. 28, 358-362 (1985).
15. J. P. Karkas, J. Germershausen, R. L. Tolman, M. MacCoss, A. F. Wagner, R. Liou, and R. Bosteder, Biochim. Biophys. Acta 911, 127-135 (1987).
16. M. MacCoss and R. Tolman, Eur. Patent Appin. 074, 306, 1985.
17. R. L. Tolman, A. K. Field, J. D. Karkas, A. F. Wagner, J. Germershausen, C. Crumpacker, and E. M. Scolnik, Biochem. Biophys. Res. Commun. 128, 1329-1335 (1985).
18. E. J. Prisbe, J. C. Martin, D. P. C. McGee, M. F. Barker, D. F. Smee, A. E. Duke, T. R. Mattews, and J. P. H. Verheyden, J. Med. Chem. 29, 671-675 (1986).
19. L. Dudycz, A. Kotlicki, and D. Shugar, Carbohydr. Res. 91, 31-36 (1981).
20. A. S. Jones, M. J. McLean, H. Tanaka, R. T. Walker, J. Balzarini, and E. De Clercq, Tetrahedron 41, 5965-5972 (1985).
21. M. Yoshikawa, T. Kato, and T. Takenishi, Bull. Chem. Soc. Japan 42, 3505-3508 (1969).
22. M. Hubert-Habart and L. Goodman, Chem. Commun. 1969, 740-741.
23. G. I. Birnbaum and D. Shugar, in: Topics in Nucleic Acid Chemistry (S. Neidle, ed.) 1987, pp. 1-70.
24. R. Marumoto, T. Nishimura, and M. Hanjo, Chem. Pharm. Bull. (Tokyo) 23, 2295-2300 (1975).
25. D. M. Helfman and J. F. Kuo, J. Biol. Chem. 257, 1044-1047 (1982).
26. C. A. G. Haasnoot, F. A. A. M. de Leeuv, and C. Altona, Tetrahedron 36, 2783-2792 (1980).
27. M. McCoss, F. S. Ezra, M. J. Robins, and S. S. Danyluk, J. Am. Chem. Soc. 99, 7495-7502 (1977).
28. C. J. Blackburn, R. D. Lapper, and I. C. P. Smith, J. Am. Chem. Soc. 95, 2873-2878 (1973).
29. D. B. Davies, P. Rajani, and H. Sadikot, J. Chem. Soc. Perkin Trans II 1985, 279-285.
30. R. Stolarski, C.-E. Hagberg, and D. Shugar, Eur. J. Biochem. 138, 187-192 (1984).
31. D. E. Dorman, D. Bauer, and J. D. Roberts, J. Organ. Chem. 40, 3729-3735 (1975).
32. G. K. Hamer, F. Balza, N. Cyr, and A. S. Perlin, Can. J. Chem. 56, 3109-3116 (1978).
33. G. I. Birnbaum, R. Stolarski, Z. Kazimierczuk, and
34. D. Shugar, Can. J. Chem. 63, 1215-1221 (1985).
35. G. I. Birnbaum, M. Cygler, J. T. Kumierek, and D. Shugar, Biochem. Biophys. Res. Commun. 103, 968-973 (1981).
36. S. V. Gupta, G. Tourigny, A. L. Stuart, E. De Clercq, J. W. Quail, I. Ekiel, O. A. L. El-Kabbani, and L. T. J. Delbaere, Antiviral Res. 7, 69-77 (1987).
37. This is the nomenclature employed by the authors. Actually this should be 1-(2’-deoxy-ß-D-threo-pentofuranosyl)-5-methoxy-methyluracil.
38. L. M. Lerner and R. R. Rossi, Biochemistry 11, 2772-2777 (1972).
39. R. R. Rossi and L. M. Lerner, J. Med. Chem. 16, 457-460 (1973).
40. M. J. Schaeffer and P. S. Bhargava, Biochemistry 4, 71-76 (1965).
41. J. A. Secrist III, J. A. Montgomery, Y. F. Shealy, C. A. O’Dell, and S. J. Clayton, J. Med. Chem. 30, 746-749 (1987).
42. T. Braumann, C. Erneux, G. Petridis, W.-D. Stohrer, and B. Jastorff, Biochim. Biophys. Acta 871, 746-749 (1987).
43. E. G. Brown and R. P. Newton, Phytochemistry 20, 2453-2463 (1981).